company background image
REKA logo

Rekah Pharmaceutical Industry TASE:REKA Stock Report

Last Price

₪12.35

Market Cap

₪141.0m

7D

0.8%

1Y

-25.6%

Updated

15 Jun, 2024

Data

Company Financials

Rekah Pharmaceutical Industry Ltd.

TASE:REKA Stock Report

Market Cap: ₪141.0m

REKA Stock Overview

Engages in the manufacture, marketing, sale, and distribution of prescription and OTC drugs, dermo-cosmetics, vitamins, and nutritional supplements in Israel.

REKA fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Rekah Pharmaceutical Industry Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Rekah Pharmaceutical Industry
Historical stock prices
Current Share Price₪12.35
52 Week High₪18.87
52 Week Low₪12.00
Beta0.0021
1 Month Change-1.59%
3 Month Change-13.39%
1 Year Change-25.56%
3 Year Change-53.26%
5 Year Change-48.92%
Change since IPO-96.47%

Recent News & Updates

Here's Why Rekah Pharmaceutical Industry Ltd.'s (TLV:REKA) CEO May Not Expect A Pay Rise This Year

Dec 14
Here's Why Rekah Pharmaceutical Industry Ltd.'s (TLV:REKA) CEO May Not Expect A Pay Rise This Year

Rekah Pharmaceutical Industry (TLV:REKA) Has A Somewhat Strained Balance Sheet

Sep 12
Rekah Pharmaceutical Industry (TLV:REKA) Has A Somewhat Strained Balance Sheet

Recent updates

Here's Why Rekah Pharmaceutical Industry Ltd.'s (TLV:REKA) CEO May Not Expect A Pay Rise This Year

Dec 14
Here's Why Rekah Pharmaceutical Industry Ltd.'s (TLV:REKA) CEO May Not Expect A Pay Rise This Year

Rekah Pharmaceutical Industry (TLV:REKA) Has A Somewhat Strained Balance Sheet

Sep 12
Rekah Pharmaceutical Industry (TLV:REKA) Has A Somewhat Strained Balance Sheet

Estimating The Fair Value Of Rekah Pharmaceutical Industry Ltd. (TLV:REKA)

Jul 19
Estimating The Fair Value Of Rekah Pharmaceutical Industry Ltd. (TLV:REKA)

Rekah Pharmaceutical Industry's (TLV:REKA) Problems Go Beyond Weak Profit

Apr 13
Rekah Pharmaceutical Industry's (TLV:REKA) Problems Go Beyond Weak Profit

We Think Rekah Pharmaceutical Industry (TLV:REKA) Is Taking Some Risk With Its Debt

May 12
We Think Rekah Pharmaceutical Industry (TLV:REKA) Is Taking Some Risk With Its Debt

Here's Why I Think Rekah Pharmaceutical Industry (TLV:REKA) Might Deserve Your Attention Today

Apr 09
Here's Why I Think Rekah Pharmaceutical Industry (TLV:REKA) Might Deserve Your Attention Today

Does Rekah Pharmaceutical Industry's (TLV:REKA) Share Price Gain of 50% Match Its Business Performance?

Mar 12
Does Rekah Pharmaceutical Industry's (TLV:REKA) Share Price Gain of 50% Match Its Business Performance?

Rekah Pharmaceutical Industry Ltd.'s (TLV:REKA) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Feb 19
Rekah Pharmaceutical Industry Ltd.'s (TLV:REKA) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Is Rekah Pharmaceutical Industry (TLV:REKA) Using Too Much Debt?

Jan 29
Is Rekah Pharmaceutical Industry (TLV:REKA) Using Too Much Debt?

Here's Why I Think Rekah Pharmaceutical Industry (TLV:REKA) Is An Interesting Stock

Jan 08
Here's Why I Think Rekah Pharmaceutical Industry (TLV:REKA) Is An Interesting Stock

How Is Rekah Pharmaceutical Industry's (TLV:REKA) CEO Paid Relative To Peers?

Dec 18
How Is Rekah Pharmaceutical Industry's (TLV:REKA) CEO Paid Relative To Peers?

Investors Who Bought Rekah Pharmaceutical Industry (TLV:REKA) Shares Five Years Ago Are Now Up 33%

Nov 30
Investors Who Bought Rekah Pharmaceutical Industry (TLV:REKA) Shares Five Years Ago Are Now Up 33%

Shareholder Returns

REKAIL PharmaceuticalsIL Market
7D0.8%-2.0%0.5%
1Y-25.6%-14.9%-4.8%

Return vs Industry: REKA underperformed the IL Pharmaceuticals industry which returned -14.9% over the past year.

Return vs Market: REKA underperformed the IL Market which returned -4.8% over the past year.

Price Volatility

Is REKA's price volatile compared to industry and market?
REKA volatility
REKA Average Weekly Movement5.4%
Pharmaceuticals Industry Average Movement5.3%
Market Average Movement4.5%
10% most volatile stocks in IL Market8.1%
10% least volatile stocks in IL Market3.3%

Stable Share Price: REKA has not had significant price volatility in the past 3 months.

Volatility Over Time: REKA's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1941427Mordechai Elgrabliwww.rekah.co.il

Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of prescription and OTC drugs, dermo-cosmetics, vitamins, and nutritional supplements in Israel. The company offers steroid tablets; antibiotics, including penicillin and cephalosporin; drops and ointments to treat allergies, infections, and dryness of the eyes; baby products; and dermatological preparations. Its portfolio of products comprise approximately 280 drugs used in various medical fields.

Rekah Pharmaceutical Industry Ltd. Fundamentals Summary

How do Rekah Pharmaceutical Industry's earnings and revenue compare to its market cap?
REKA fundamental statistics
Market cap₪140.97m
Earnings (TTM)-₪6.29m
Revenue (TTM)₪332.33m

0.4x

P/S Ratio

-22.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
REKA income statement (TTM)
Revenue₪332.33m
Cost of Revenue₪249.52m
Gross Profit₪82.81m
Other Expenses₪89.10m
Earnings-₪6.29m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.55
Gross Margin24.92%
Net Profit Margin-1.89%
Debt/Equity Ratio86.5%

How did REKA perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.